Fig. 3: Anticoagulation for patients with LVA and apical segment akinesis. | Nature Communications

Fig. 3: Anticoagulation for patients with LVA and apical segment akinesis.

From: Clinical characteristics and prognostic importance of anticoagulant use in ischemic left ventricular aneurysm: a retrospective cohort study

Fig. 3

Kaplan-Meier event-free survival curve in patients with LVA and apical segment akinesis according to anticoagulation status (without anticoagulant use: n = 309; with anticoagulant use: n = 128): (A) Net adverse clinical events (B) All-cause mortality (C) Systemic embolism events (D) Major bleeding events. Source data are provided as a Source Data file. Abbreviations: LVA left ventricular aneurysm.

Back to article page